NCT06520202: An ongoing trial by Lubris Bio Pty Ltd
This trial is ongoing. It must report results 3 weeks, 4 days ago.
Full data
| Full entry on ClinicalTrials.gov | NCT06520202 |
|---|---|
| Title | A PHASE II PROSPECTIVE RANDOMIZED CROSSOVER STUDY ASSESSING THE ACUTE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 5, 2024 |
| Completion date | Nov. 11, 2024 |
| Required reporting date | Nov. 11, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |